TECOGEN INC. Files 8-K on Financials

Ticker: TGEN · Form: 8-K · Filed: Aug 12, 2025 · CIK: 1537435

Tecogen Inc. 8-K Filing Summary
FieldDetail
CompanyTecogen Inc. (TGEN)
Form Type8-K
Filed DateAug 12, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

TECOGEN INC. dropped an 8-K on August 12, 2025, with financial updates.

AI Summary

On August 12, 2025, TECOGEN INC. filed an 8-K report detailing results of operations and financial condition. The filing also included Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and headquartered in North Billerica, Massachusetts.

Why It Matters

This 8-K filing provides investors with crucial updates on TECOGEN INC.'s financial performance and operational status, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or significant risks.

Key Players & Entities

  • TECOGEN INC. (company) — Registrant
  • August 12, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • 76 Treble Cove Road, Building 1 North Billerica, Massachusetts 01862 (address) — Principal Executive Offices
  • 001-36103 (company_id) — Commission File Number

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on TECOGEN INC.'s results of operations and financial condition, along with Regulation FD disclosures and financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on August 12, 2025.

In which state is TECOGEN INC. incorporated?

TECOGEN INC. is incorporated in Delaware.

What is TECOGEN INC.'s principal executive office address?

TECOGEN INC.'s principal executive office is located at 76 Treble Cove Road, Building 1, North Billerica, Massachusetts 01862.

What is TECOGEN INC.'s telephone number?

TECOGEN INC.'s telephone number is (781) 466-6400.

Filing Stats: 640 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2025-08-12 17:28:38

Key Financial Figures

  • $0.001 — ange on which registered Common Stock, $0.001 par value per share TGEN NYSE American,

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On August 12, 2025, Tecogen Inc. (the "Company") issued a press release with earnings commentary and supplemental information for the three and six months ended June 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing. Section 7.01 - Regulation FD Disclosure

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure On August 13, 2025, the Company will present the attached slides online in connection with an earnings conference call. The slides are being furnished as Exhibit 99.2 to this Current Report on Form 8-K. The information in this Item 7.01 and Exhibit 99.2 to this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing. Section 9 - Financial Statements and Exhibits

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release, dated August 12, 2025 * 99.2 Earnings Call Presentation, dated August 13, 2025 * * Filed herewith.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. TECOGEN INC. By: /s/ Abinand Rangesh August 12, 2025 Abinand Rangesh, Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.